Articles

Treatment and outcomes for chronic myelomonocytic leukemia compared to myelodysplastic syndromes in older adults

Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore MD
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore MD
Department of Oncology, The Johns Hopkins University, Baltimore, MD and Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Division of Hematology/Oncology, Department of Medicine, University of Maryland School of Medicine and Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore MD;Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, MD
Agency for Healthcare Research and Quality, Center for Financing, Access, and Cost Trends, U.S. Department of Health and Human Services, Rockville, MD, USA
Vol. 98 No. 4 (2013): April, 2013 https://doi.org/10.3324/haematol.2012.062547